Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-24 @ 7:08 PM
NCT ID:
NCT00811057
Eligibility Criteria:
Inclusion Criteria:
* Pregnancies with intact membranes in confirmed preterm labor;
* 20 - 32 weeks' gestation;
* Cervical dilatation 0 - 3cm versus 4 - 6cm;
* No conditions contraindicating continued pregnancy (severe IUGR, chorioamnionitis, non-reassuring fetal tracing - physician judgement); AND
* Able and willing to consent to the study protocol.
Exclusion Criteria:
* Failure to meet admission criteria;
* Known serious fetal malformations;
* Severe maternal/obstetric disease affecting the mother or fetus (severe cardiac disease, placental abruption/previa, severe diabetes, severe preeclampsia, etc. - physician judgment);
* Allergic to magnesium, antiprostaglandin or calcium channel antagonist;
* Refusal or inability to consent to the study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
16 Years
Maximum Age:
45 Years
Study:
NCT00811057
Study Brief:
Protocol Section:
NCT00811057